ClinicalTrials.Veeva
Menu

Find clinical trials for Adenocarcinoma in Cincinnati, OH

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Pancreatic Cancer
Stomach Cancer
Non-Small-Cell Lung Carcinoma
Colorectal Cancer
Prostatic Cancer
Esophageal Cancer
Cancer

Adenocarcinoma trials near Cincinnati, OH, USA:

Phase 1 Study Evaluating BA3182 in Patients With Advanced Adenocarcinoma.

The objective of this study is to assess safety and efficacy of BA3182 in Advanced Adenocarcinoma...

Enrolling
Advanced Adenocarcinoma
Drug: BA3182

Phase 1

BioAtla

Cincinnati, Ohio, United States and 8 other locations

The purpose of this study is to evaluate the safety and efficacy of a novel RAS(ON) inhibitor compared to standard(s) of care (SOC) treatment.

Active, not recruiting
PDAC - Pancreatic Ductal Adenocarcinoma
PDAC
Drug: 5-fluorouracil
Drug: leucovorin

Phase 3

Revolution Medicines
Revolution Medicines

Cincinnati, Ohio, United States and 59 other locations

in individuals with pathologically confirmed pancreatic ductal adenocarcinoma. Following screening, using a standardized administration prot...

Enrolling
Pancreatic Ductal Adenocarcinoma (PDAC)
Drug: [18F]FAPI-74 PET/CT

Phase 3

SOFIE

Kettering, Ohio, United States and 9 other locations

, gastroesophageal junction or esophageal adenocarcinoma Be treatment naïve for advanced or metastatic disease Be in good physical condition...

Enrolling
Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction , or Esophageal Adenocarcinoma
Esophageal Adenocarcinoma
Biological: Nivolumab
Biological: PF-08634404

Phase 2, Phase 3

Pfizer
Pfizer

Cincinnati, Ohio, United States and 56 other locations

Zolbetuximab is being studied in people with cancer in and around the stomach or where the food pipe (esophagus) joins the stomach, called gastroesop...

Enrolling
Metastatic Gastric Adenocarcinoma or Cancer
Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer
Drug: 5-fluorouracil (5-FU)
Drug: Capecitabine

Phase 3

Astellas
Astellas

Edgewood, Kentucky, United States and 223 other locations

This is an open label Phase 2 study to evaluate the efficacy and safety of ACR-368 as monotherapy or with ultra-low dose gemcitabine (ULDG) sensitiza...

Enrolling
Endometrial Adenocarcinoma
Drug: ACR-368
Diagnostic Test: OncoSignature

Phase 2

Acrivon Therapeutics

Cincinnati, Ohio, United States and 89 other locations

Pancreatic cancer is difficult to diagnose early. By the time people have been diagnosed, the cancer has usually spread to other parts of the body (m...

Enrolling
Metastatic Pancreatic Adenocarcinoma
Metastatic Pancreatic Cancer
Drug: Oxaliplatin
Drug: Leucovorin

Phase 3

Astellas
Astellas

Edgewood, Kentucky, United States and 12 other locations

and safety of AZD0901 compared to Investigator's choice of therapy as 2L+ treatment for participants with advanced or metastatic gastric or GEJ adenocarcinoma...

Enrolling
Gastroesophageal Junction Cancer
Gastric Cancer
Drug: Docetaxel
Drug: Irinotecan

Phase 3

AstraZeneca
AstraZeneca

Cincinnati, Ohio, United States and 185 other locations

mFOLFIRINOX alone in participants with resected pancreatic ductal adenocarcinoma (PDAC) who have not received prior systemic anti-cancer tre...

Enrolling
Adenocarcinoma, Pancreatic Ductal
Drug: mFOLFIRINOX
Drug: Autogene cevumeran

Phase 2

Genentech
Genentech

Cincinnati, Ohio, United States and 89 other locations

Zolbetuximab is being studied in people with cancer in and around the stomach or where the food pipe (esophagus) joins the stomach, called gastroesop...

Active, not recruiting
Metastatic Gastric Adenocarcinoma or Cancer
Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer
Drug: folinic acid
Drug: zolbetuximab

Phase 3

Astellas
Astellas

Middletown, Ohio, United States and 219 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems